DelSiTech Awarded a Grant to Develop Controlled and Sustained Release Injectables for Prophylactic HIV Vaccine Aleksi Leino2023-03-15T11:34:26+03:00March 15th, 2023| Read More
DelSiTech Ltd Announces Appointment of Dr. Sari Häkkinen as Chief Development Officer Aleksi Leino2023-03-22T16:06:07+03:00March 1st, 2023| Read More
CRS Long-acting injectables conference 2023 February 8-9 Ossi Leppänen2022-12-05T19:18:09+03:00December 4th, 2022| Read More
CPHI 2022 Frankfurt, November 1-3 Ossi Leppänen2022-10-12T13:37:23+03:00October 12th, 2022| Read More
Partnering Opportunities in Drug Delivery 2022 Boston, October 24-25 Ossi Leppänen2022-10-12T13:30:40+03:00October 12th, 2022| Read More
DelSiTech Starts a Clinical Trial with Its Eye Drop Product Ossi Leppänen2022-09-14T15:40:45+03:00September 14th, 2022| Read More
BIO-Europe 2022 Leipzig, October 24-26 Ossi Leppänen2022-10-12T13:33:54+03:00July 24th, 2022| Read More
Eyecelerator & American Academy of Ophthalmology 2022 Conference Chicago, Sep 29 – Oct 3 Ossi Leppänen2022-09-14T09:20:12+03:00July 6th, 2022| Read More
